As of 2025-07-04, the EV/EBITDA ratio of ACRO Biomedical Co Ltd (ACBM) is -0.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ACBM's latest enterprise value is 0.12 mil USD. ACBM's TTM EBITDA according to its financial statements is -15.15 mil USD. Dividing these 2 quantities gives us the above ACBM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 11.1x | 9.1x |
| Forward P/E multiples | 5.7x - 11.1x | 8.4x |
| Fair Price | (1.79) - (2.80) | (2.21) |
| Upside | -256226.9% - -400416.5% | -315705.1% |
| Date | EV/EBITDA |